AET - Aetna Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
181.71
+0.14 (+0.08%)
As of 3:13PM EST. Market open.
Stock chart is not supported by your current browser
Previous Close181.57
Open181.33
Bid181.83 x 100
Ask181.93 x 100
Day's Range181.24 - 182.43
52 Week Range116.04 - 192.37
Volume2,145,365
Avg. Volume2,973,910
Market Cap59.269B
Beta0.54
PE Ratio (TTM)34.51
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.00 (1.09%)
Ex-Dividend Date2017-10-11
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch2 days ago

    UnitedHealth is stepping past CVS Health with its latest deal

    While rivals are copying UnitedHealth, the company has raised the bar again, one Wall Street analyst said.

  • Reuters4 days ago

    BUZZ-U.S. stocks weekly: Still in business

    ** S&P 500 posts 0.4 pct weekly gain and notches record high close on Fri, helped by robust Nov hiring data and legislation averting a government shutdown ** That said, tech's recent stumble has put a ...

  • Discount Retail Stocks, LULU Earnings, & Healthcare Consolidation
    Zacks4 days ago

    Discount Retail Stocks, LULU Earnings, & Healthcare Consolidation

    On today's episode of the Zacks Friday Finish Line, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week's biggest stories, including the latest earnings results from Dollar General (DG) and Lululemon (LULU), as well as major healthcare M&A deals involving CVS (CVS), Aetna (AET), and UnitedHealth (UNH).

  • Reuters4 days ago

    CVS expects U.S. Justice Department to handle review of Aetna deal

    CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said. CVS Health Corp and Aetna announced the $69 billion (£51.4 billion) deal on Dec. 3, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies. The Justice Department and U.S. Federal Trade Commission share the job of reviewing mergers to make sure they do not hurt consumers.

  • CVS Health Corp Buys Aetna. So Who Is Going To Buy Rite Aid?
    InvestorPlace4 days ago

    CVS Health Corp Buys Aetna. So Who Is Going To Buy Rite Aid?

    The combination of CVS Health Corp (NYSE:CVS) with Aetna Inc (NYSE:AET) seems like a strong move, and it raises questions as to who will scoop up Rite Aid Corporation (NYSE:RAD) and its stores and pharmacy management business. This may save both firms money because people may be enticed to use CVS clinics instead of going to the doctor. In addition, when people go to the clinics, they’ll be right there in a CVS store.

  • CVS expects Justice Department to handle review of Aetna deal
    Reuters4 days ago

    CVS expects Justice Department to handle review of Aetna deal

    CVS Health Corp expects the U.S. Justice Department to do the antitrust review of its planned acquisition of health insurer Aetna Inc, a spokesman for the drugstore chain operator said. CVS Health Corp and Aetna announced the $69 billion deal on Dec. 3, arguing it would enable the companies to tackle soaring healthcare spending by offering lower-cost medical services in pharmacies. The Justice Department and U.S. Federal Trade Commission share the job of reviewing mergers to make sure they do not hurt consumers.

  • Motley Fool4 days ago

    Tax Reform Takes a Bite Out of Biotech Stocks

    The two GOP tax bills include provisions that would kill longstanding tax breaks that drug developers depend on. Plus, CVS Health cozies up to Aetna and Apple takes aim at heart disease.

  • Motley Fool5 days ago

    Will CVS Get the Chance to Buy Aetna?

    The pharmacy giant and the health insurance have little real overlap, but the combination could be viewed as harmful to consumers.

  • CVS’s $68 Billion Bid to Bring One-Stop Shopping to Health Care
    Bloomberg5 days ago

    CVS’s $68 Billion Bid to Bring One-Stop Shopping to Health Care

    The purchase could shunt thousands of Aetna customers to the retailer’s health centers and transform the way America goes to the doctor.

  • Moody's5 days ago

    RMF Euro CDO V plc -- Moody's assigns Chloe B2 CFR, B2 first-lien debt

    Rating Action: Moody's assigns Chloe B2 CFR, B2 first-lien debt. Global Credit Research- 07 Dec 2017. $295 million of newly rated debt.

  • The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy
    Zacks5 days ago

    The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

    The Zacks Analyst Blog Highlights: Aetna, CareDx, PRA Health Sciences and Diplomat Pharmacy

  • Ascension, Providence St. Joseph in talks for merger
    Yahoo Finance Videoyesterday

    Ascension, Providence St. Joseph in talks for merger

    Two major hospitals, Ascension and Providence Saint Joseph Health are in talks about a possible merger. Yahoo Finance’s Alexis Christoforous and Melody Hahm discuss what a merger would mean for patients.

  • The Week That Was: Bitcoin soars, government shutdown ave...
    CNBC Videos4 days ago

    The Week That Was: Bitcoin soars, government shutdown ave...

    CNBC's Dominic Chu looks back at the week's top business and financial stories.